Page
%P
-
Article
Open AccessConventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects...